Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Koundakijan EJ et al. | 1996 | intact cell/cell culture, embryonic cells from <i>Drosophila melanogaster</i> | magnetic field, 50/60 Hz, co-exposure | 10–100 µT |
Villarini M et al. | 2017 | intact cell/cell culture, SH-SY5Y and SK-N-BE-2 (human neuroblastoma cell lines) | magnetic field, 50/60 Hz, co-exposure, also other exposures without EMF | 0.01–1 mT |
Coulton LA et al. | 2004 | blood samles | magnetic field, 50/60 Hz | 20–100 µT |
Junkersdorf B et al. | 2000 | invertebrate, nematode (<i>Caenorhabditis elegans</i>)/pPCZ1 and pD2047 | magnetic field, 50/60 Hz, co-exposure | 50–200 µT |
Alfieri RR et al. | 2006 | intact cell/cell culture, human leukemia & lymphoma cells (CEM lymphoblastoic leukemia CD4+ cells; U937 (histiocytic lymphoma cells); HL60 (promyelocytic leukemia cells)); endothelial cells (of pig pulmonary arteries; HUVEC cultures); human fibroblasts (WI38 & HuDe (from derma)) | magnetic field, 50/60 Hz | 55–680 µT |
Tokalov SV et al. | 2003 | intact cell/cell culture, HL-60 cells (human acute myeloid leukaemia cell line) | magnetic field, 50/60 Hz, also other exposures without EMF, co-exposure | 60 µT |
Rodriguez-De la Fuente AO et al. | 2012 | animal, mouse/BALB/c (quadriceps muscle transfected with an EMF plasmid) | magnetic field, low frequency, 50/60 Hz, co-exposure | 80 µT |
Shi B et al. | 2003 | intact cell/cell culture, human keratinocytes | magnetic field, 50/60 Hz | 100 µT |
Wang Y et al. | 2019 | intact cell/cell culture, human ventricular cardiomyocytes cell line (AC16), animal, rat/Sprague Dawley, whole body | 50/60 Hz, magnetic field | 100 µT |
Malagoli D et al. | 2006 | invertebrate, mussel/<i>Mytilus galloprovincialis</i> | magnetic field, 50/60 Hz | 100–800 µT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.